Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study Meeting Abstract
| Authors: | Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; Comenzo, R. |
| Abstract Title: | Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study |
| Meeting Title: | 51st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 114 |
| Issue: | 22 |
| Meeting Dates: | 2009 Dec 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2009-11-20 |
| Start Page: | 222 |
| End Page: | 223 |
| Language: | English |
| ACCESSION: | WOS:000272725800534 |
| PROVIDER: | wos |
| PUBMED: | 22276299 |
| DOI: | 10.1182/blood.V114.22.533.533 |
| Notes: | Meeting Abstract: 533 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
